Noradrenalină Kalceks (Norepinephrine)

Norepinephrine, the active ingredient in Noradrenalină Kalceks, is a sympathomimetic agent presented as a solution for intravenous use. It is employed to raise blood pressure in acute hypotensive states such as septic shock and cardiac arrest.

GNH USA supplies Noradrenalină Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenalină Kalceks acts on the sympathetic vascular pathway to restore circulatory stability in critical care settings.

- Hypotension: restores vascular tone and raises systemic blood pressure. - Septic shock: improves perfusion pressure in distributive shock. - Cardiac arrest: supports circulation during resuscitation efforts.

Norepinephrine may cause a range of adverse reactions that vary with dose and patient condition.

Common Side Effects: - Tachycardia: increased heart rate. - Headache: pressure sensation. - Anxiety or restlessness. - Peripheral ischemia: reduced blood flow to extremities. - Nausea or vomiting.

Serious or Rare Side Effects: - Severe hypertension: dangerously high blood pressure. - Myocardial ischemia: reduced heart muscle oxygen. - Tissue necrosis at injection site. - Pulmonary edema: fluid accumulation in lungs. - Cardiac arrest: loss of effective circulation.

When using Noradrenalină Kalceks, careful monitoring and specific safety measures are essential.

- Cardiac monitoring: continuous ECG to detect arrhythmias. - Blood pressure monitoring: maintain target MAP and avoid excessive rise. - Dose titration: adjust infusion rate based on hemodynamic response. - Contraindications: avoid in patients with pheochromocytoma or uncorrected hypovolemia. - Caution in myocardial ischemia: use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Norepinephrine can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive sympathomimetic effect. - Beta‑blockers: may blunt pressor response.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may reduce efficacy. - Diuretics: affect intravascular volume and response. - Calcium channel blockers: may alter vascular tone.